Log In
Print this Print this

Exjade (deferasirox) (ICL670)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionIron chelating agent
Molecular Target Not available
Mechanism of ActionChelating agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today